Atai Life Sciences NV 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
ATAI Life Sciences' 2024 10-K filing reveals a year of strategic shifts, clinical advancements, and financial recalibration in the pursuit of mental health treatments.
NASDAQ
ATAI Life Sciences N.V.'s 10-K filing provides a comprehensive overview of its share capital, articles of association, and corporate governance practices, highlighting its commitment to developing treatments for mental health disorders.